European Union - English - EMA (European Medicines Agency)

medimmune llc - reassortant influenza virus (live attenuated) of the following strains:a/california/7/2009 (h1n1)pdm09 like strain, a/victoria/361/2011 (h3n2) like strain, b/massachusetts/2/2012 like strain - influenza, human; immunization - vaccines - prophylaxis of influenza in individuals 24 months to less than 18 years of age.the use of fluenz should be based on official recommendations.

European Union - English - EMA (European Medicines Agency)

astrazeneca ab - a/darwin/9/2021 (h3n2) - like strain (a/norway/16606/2021, medi 355293) / a/victoria/2570/2019 (h1n1)pdm09 - like strain (a/victoria/1/2020, medi 340505) / b/austria/1359417/2021 - like strain (b/austria/1359417/2021, medi 355292) / b/phuket/3073/2013 - like strain (b/phuket/3073/2013, medi 306444) - influenza, human - influenza vaccines, influenza, live attenuated - prophylaxis of influenza in children and adolescents from 24 months to less than 18 years of age. the use of fluenz tetra should be based on official recommendations.

European Union - English - EMA (European Medicines Agency)

astrazeneca ab - reassortant influenza virus (live attenuated) of the following strain: a/vietnam/1203/2004 (h5n1) strain - influenza, human - vaccines - prophylaxis of influenza in an officially declared pandemic situation in children and adolescents from 12 months to less than 18 years of age.pandemic influenza vaccine h5n1 astrazeneca should be used in accordance with official guidance

Canada - English - Health Canada

astrazeneca canada inc - influenza virus type a (h1n1); influenza virus type a (h3n2); influenza virus type b - spray - 10000000ffu; 10000000ffu; 10000000ffu - influenza virus type a (h1n1) 10000000ffu; influenza virus type a (h3n2) 10000000ffu; influenza virus type b 10000000ffu - vaccines

Canada - English - Health Canada

astrazeneca canada inc - influenza virus type a (h1n1); influenza virus type a (h3n2); influenza virus type b (victoria); influenza virus type b (yamagata) - spray - 32000000ffu; 32000000ffu; 32000000ffu; 32000000ffu - influenza virus type a (h1n1) 32000000ffu; influenza virus type a (h3n2) 32000000ffu; influenza virus type b (victoria) 32000000ffu; influenza virus type b (yamagata) 32000000ffu - vaccines

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

astrazeneca uk ltd - influenza virus live attenuated - spray

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - a/california/7/2009 (h1n1) 15 mcg / 0.5 ml; a/victoria/361/2011 (h3n2) 15 mcg / 0.5 ml - suspension for injection - influenza, live attenuated - prophylaxis of influenza, especially those who run an increased risk of associated complications. fluarix is indicated in adults and children from 6 months of age.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

astrazeneca uk ltd - influenza virus live attenuated - spray

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

astrazeneca uk ltd - influenza virus live attenuated - spray